Seminars in Arthritis and Rheumatism

Article	Citations
Genetics of psoriasis spectrum disease – Advances in targeted therapeutics meeting	123
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	84
Defining immune cell phenotypes that distinguish treatment responders and non-responders in RA	72
Immunotherapy in cancer	70
Regulation of T peripheral helper and T follicular helper cells in lupus	66
Aortic disease in giant cell arteritis	66
Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients	62
Ultrasound evaluation contrasts clinical disease activity evaluation in rheumatoid arthritis patients with concomitant anxiety or depression	62
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	60
Probing the synovium-brain axis	57
The operational definition of old age and impact on outcomes in DMARD-treated patients with rheumatoid arthritis: A systematic literature review	48
The effects of menopausal hormone therapy for the risk of systemic lupus erythematosus: A nationwide cohort study in Korea	47
Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: A scoping review	46
Venous ulcers in Behçet syndrome	46
Age of onset of rheumatoid arthritis and radiographic changes	43
Are participants in gout medication registration clinical trials representative of people with gout in the general population?	43
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	38
The Fifth Element: Is Vascular Dysfunction an Intrinsic Feature of Gout?	34
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	34
Giant cell arteritis – New treatment targets at the horizon	34
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	34
How to analyze and understand the human immune system	33
What is Surveillance teaching us (and what it is not?)	32
Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study	32
Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity	32

Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: Analysis of the ASAS-perSpA study	32
Editorial Board	32
ANCA status and renal parameters at month 12 post-diagnosis can help predict subsequent relapses in patients with granulomatosis with polyangiitis	30
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	29
The cause is worse than the effect: Inequities in the United States health system; how could we change them?	29
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus	29
Rheumatoid arthritis prevention: We need to identify new targets for “NextGen” therapeutic trials	29
Dactylitis: Good for diagnosis, bad for treatment	28
A letter to: A meta-analysis of clinical manifestations in Asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	27
A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis	25
Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study	25
Pediatric-onset Takayasu arteritis is associated with greater risk of mortality than adult-onset Takayasu arteritis–A systematic review with meta-analysis of observational cohort studies	24
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	24
Correspondence on “low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort” by Wysham et al.	23
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	23
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative	23
mRNA vaccines in the rheumatologist's future	22
How can genetics analysis allow for early detection of rheumatoid arthritis	22
Response to comments on “The phenotype of mixed connective tissue disease patients having associated interstitial lung disease” by Chevalier K et al. and Shih PC	22
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity	21
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	21
Commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French study	21
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register	21
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	21
Qualitative evaluation of connective tissue disease with cytomegalovirus infection: A meta-analysis of case reports	21
Response to “Do not ignore another risk factor of invasive fungal infections in patients with connective tissue disease”	20
Response letter to the editor	20
Letter to the editor:” International, multidisciplinary delphi consensus recommendations on non-pharmacological interventions for fibromyalgia”	20
Letter to the editor: Response to “COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis” by Batu et al.	20
Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice	19
Editorial Board	19
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients	18
Effects of body weight and fat mass on back pain – direct mechanical or indirect through inflammatory and metabolic parameters?	18
Prediction models for treatment success after an interdisciplinary multimodal pain treatment program	18
Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1 inhibitors	18
Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review	18
Pediatric rheumatology: Not just a little adult workforce issue	18
Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review	18
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	18
Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: A meta-analysis and systematic review	18
High prevalence and incidence of systemic sclerosis in Reunion Island, a French multi-ethnical and tropical territory	18
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative	17
Septic arthritis of native joints due to Mycobacterium avium complex: A systematic review of case reports	17
Axial involvement in psoriatic arthritis: An update for rheumatologists	17
Pregnancy in women with psoriatic arthritis: A systematic literature review of disease activity and adverse pregnancy outcomes	17
OMERACT Filter 2.1 instrument selection for physical function domain in psoriatic arthritis: Provisional endorsement for HAQ-DI and SF-36 PF	17
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process	17
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease	16
Urate-lowering efficacy and renal safety of febuxostat in patients with hyperuricemia and stage 4–5 chronic kidney disease not yet on dialysis: A meta-analysis of observational studies	16
Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review	16

Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	16
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	16
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	16
Telemedicine in rheumatology care: A systematic review	16
Risk of venous thromboembolism in Korean patients with rheumatoid arthritis treated with Janus kinase inhibitors: A nationwide population-based study	16
Arthritis and enthesitis in the hip and pelvis region in spondyloarthritis - OMERACT validation of two whole-body MRI methods	16
Timing of sinusitis and other respiratory tract diseases and risk of rheumatoid arthritis	16
A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome	16
Physicians’ vs patients’ global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies	16
Rheumatology tolerance for cure (RTCure) – an IMI project aimed at prevention and cure of RA	16
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review	15
Systemic lupus erythematosus in American Indian/Alaska natives: Incorporating our new understanding of the biology of trauma	15
Whole phenotype of patients with systemic sclerosis and sicca manifestations: Comparison with sicca manifestations from other causes	15
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis	15
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	15
Acute coronary syndrome in calcium pyrophosphate deposition disease patients: A US inpatient care cohort study	15
“It means almost forgetting that you've got a disease”: An OMERACT study to define independence in the context of rheumatoid arthritis remission from the patient perspective	15
Serum antibodies to periodontal pathogens prior to rheumatoid arthritis diagnosis: A case-control study	15
Acetabular dysplasia and the risk of developing hip osteoarthritis at 2,5,8, and 10 years follow-up in a prospective nationwide cohort study (CHECK).	15
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥50 years	15
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	14
Value of ultrasound-assessed dactylitis in the early diagnosis of psoriatic arthritis	14
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network	14
Large-vessel imaging in patients with giant cell arteritis with scalp involvement: A commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French multi-center case cont	14
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) “Damage” working group report on strengths and l	14
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	14
Letter to the editor to 'Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis'	14
Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature	14
Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies	14
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	14
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	14
Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study	14
A multidisciplinary assessment of pain in juvenile idiopathic arthritis	13
Advancing composite outcome measures: Insights on weighting components from OMERACT 2023	13
Immune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis	13
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis	13
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	13
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	13
The Autoantibody response in rheumatoid arthritis; what makes it unique?	13
Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis	13
The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes	13
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	13
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group	13
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	13
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	13
OMERACT 2020: A virtual (R)evolution	13
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	13
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit	12
Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?	12
Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis	12
Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome	12
The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2	12
Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry	12
Placebo response in Raynaud's Phenomenon clinical trials: The prominent role of regression towards the mean	12
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	12
OMERACT definition and reliability assessment of chronic ultrasound lesions of the axillary artery in giant cell arteritis	12
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMER	12
Primary care-based models of care for osteoarthritis; a scoping review	12
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States	12
Suicidal behavior in patients with systematic lupus erythematosus: Systematic literature review and genetic linkage disequilibrium analysis	12
Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis	12
Co prescription of anti-acid therapy reduces the bioavailability of mycophenolate mofetil in systemic sclerosis patients: A crossover trial	11
Beyond the surface - Autoreactive B cells in human autoimmune diseases	11
A systematic review and meta-analysis of questionnaires to screen for pain sensitisation and neuropathic like pain in inflammatory arthritis	11
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial	11
The association between cigarette smoking and radiographic progression in Psoriatic Arthritis	11
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	11
Has the excess risk of acute myocardial infarction in rheumatoid arthritis relative to the general population declined? A population study of trends over time	11
Atlas of MRI findings of sacroiliitis in pediatric sacroiliac joints to accompany the updated preliminary OMERACT pediatric JAMRIS (Juvenile Idiopathic Arthritis MRI Score) scoring system: Part II: St	11
Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018	11
Impact of long COVID on self-reported disease activity, disability, and quality of life in individuals with inflammatory arthritis	11
Impairment of white matter microstructure and structural network in patients with systemic lupus erythematosus	11
Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: A meta-analysis and systematic review	11
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	11
Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review	11
Editorial Board	11
Associations of local bone involvement with disease activity, damage and functional disability in Sjögren's disease: A cross-sectional study	11
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	11
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	10
Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes	10

Pregnancy outcomes in patients treated with belimumab: Report from real-world experience	10
Bruton's tyrosine kinase – A new target for immune mediated inflammatory diseases?	10
Investigating the concomitance of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides and inflammatory bowel disease (IBD)	10
Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: A systematic review	10
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	10
Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases	10
Autonomic dysfunction in systemic sclerosis: A scoping review	10
Ultrasonographic imaging of systemic sclerosis digital ulcers: A systematic literature review and validation steps	10
Clinical features and prognosis of patients with gastrointestinal Behçet's disease-like syndrome and myelodysplastic syndrome with and without trisomy 8	10
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	10
Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”	10
Association of ultrasound-confirmed axillary artery vasculitis and clinical outcomes in giant cell arteritis	10
Correspondence on “Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis” by Weisman et al.	10
Structural damage in rheumatoid arthritis assessed by musculoskeletal ultrasound: A systematic literature review by the Structural Joint Damage Task Force of the OMERACT Ultrasound Working Group	10
Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set	10
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	9
Time to transition from psoriasis to psoriatic arthritis: A population-based study	9
Unsupervised machine-learning algorithms for the identification of clinical phenotypes in the osteoarthritis initiative database	9
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	9
Response to letter to the editor	9
Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report	9
The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review	9
Artificial intelligence as an assistant for studying treatment response in rheumatoid arthritis	9
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	9
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	9
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	9
Hounsfield Units measured in low dose CT reliably assess vertebral trabecular bone density changes over two years in axial spondyloarthritis	9
Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the “CAPS Registry”	9
Smoking-related bias of standardized mortality ratios in rheumatoid arthritis: A modeling study	9
Rheumatoid arthritis and inflammatory bowel disease: A bidirectional two-sample Mendelian randomization study	9
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	9
Best-practice clinical management of flares in people with osteoarthritis: A scoping review of behavioral, lifestyle and adjunctive treatments	9
Acknowledgement of Referees	9
The value of correctly diagnosing axial spondyloarthritis for patients and society	9
Comprehensive disease control in systemic lupus erythematosus	9
Corrigendum to Pregnancy in Axial Spondyloarthropathy: A Systematic Review & Meta-Analysis Seminars Arthritis Rheum 50 (2020):1269–1279	9
Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”	8
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	8
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	8
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	8
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	8
Development and testing of the rheumatoid arthritis quality of care survey	8
Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.	8
All-cause and specific mortality in patients with gout: A systematic review and meta-analysis	8
Correspondence to “The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis”	8
Association between work physical activity, dietary factors, and risk of rheumatoid arthritis	8
Should we really include systemic sclerosis specific antibodies in the classification criteria of Sjogren's disease?	8
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis	8
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	8
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	8
Intestinal permeability in spondyloarthritis and rheumatoid arthritis: A systematic review of the literature	8
Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions	8
Inflammatory myopathies associated with myelodysplastic syndromes: A French multicenter case control study and literature review	8
Mortality risk in patients with anti-MDA5 antibody-positive dermatomyositis: A risk assessment	8
Variations in Takayasu arteritis characteristics in a cohort of patients with different racial backgrounds	8
The value of inquiring patients about local discomfort during blood pressure measurement for fibromyalgia detection. A cross-sectional study	8
Isolated sicca syndrome and scleroderma-specific autoantibodies: Sjögren's syndrome or early Systemic Sclerosis localized in salivary glands?	8
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	8
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	8
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows	8
Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care	8
Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study	8
Erosive arthritis autoantibodies in systemic sclerosis	8
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	8
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	8